Endothelial dysfunction and renal fibrosis in endotoxemia-induced oliguric kidney injury: possible role of LPS-binding protein

[1]  I. Cinel,et al.  Sepsis and Acute Kidney Injury. , 2014, Turkish journal of anaesthesiology and reanimation.

[2]  L. Gesualdo,et al.  Endothelial-to-mesenchymal transition and renal fibrosis in ischaemia/reperfusion injury are mediated by complement anaphylatoxins and Akt pathway. , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[3]  Jie-Oh Lee,et al.  Recognition of lipopolysaccharide pattern by TLR4 complexes , 2013, Experimental & Molecular Medicine.

[4]  R. Kalluri,et al.  Origin and function of myofibroblasts in kidney fibrosis , 2013, Nature Medicine.

[5]  A. Elorza,et al.  Lipopolysaccharide induces a fibrotic-like phenotype in endothelial cells , 2013, Journal of cellular and molecular medicine.

[6]  A. Matsuda,et al.  Current trends in inflammatory and immunomodulatory mediators in sepsis , 2013, Journal of leukocyte biology.

[7]  H. O. Oudemans-van Straaten,et al.  Bench-to-bedside review: Citrate for continuous renal replacement therapy, from science to practice , 2012, Critical Care.

[8]  So-Young Lee,et al.  Distinct pathophysiologic mechanisms of septic acute kidney injury: Role of immune suppression and renal tubular cell apoptosis in murine model of septic acute kidney injury , 2012, Critical care medicine.

[9]  J. Boffa,et al.  Progression of renal fibrosis: the underestimated role of endothelial alterations , 2012, Fibrogenesis & tissue repair.

[10]  A. Wieslander,et al.  Citrate treatment reduces endothelial death and inflammation under hyperglycaemic conditions , 2012, Diabetes & vascular disease research.

[11]  M. Pozzato.  [Citrate: an additional resource for anticoagulation in continuous replacement therapy]. , 2012, Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia.

[12]  J. Bonventre,et al.  Cellular pathophysiology of ischemic acute kidney injury. , 2011, The Journal of clinical investigation.

[13]  K. Meldrum,et al.  Toll-like receptor 4: a novel signaling pathway during renal fibrogenesis. , 2011, The Journal of surgical research.

[14]  G. Müller,et al.  Endothelial Progenitor Cells in Acute Ischemic Kidney Injury: Strategies for Increasing the Cells' Renoprotective Competence , 2011, International journal of nephrology.

[15]  R. Balk,et al.  Pro-inflammatory endothelial cell dysfunction is associated with intersectin-1s down-regulation , 2011, Respiratory research.

[16]  John A Kellum,et al.  Clinical review: Blood purification for sepsis , 2011, Critical care.

[17]  T. Rabelink,et al.  Endothelial activation and circulating markers of endothelial activation in kidney disease , 2010, Nature Reviews Nephrology.

[18]  P. Bruneval,et al.  Histopathology of septic shock induced acute kidney injury: apoptosis and leukocytic infiltration , 2010, Intensive Care Medicine.

[19]  R. Kalluri,et al.  Endothelial-mesenchymal transition as a novel mechanism for generating myofibroblasts during diabetic nephropathy. , 2009, The American journal of pathology.

[20]  R. Star,et al.  Animal models of sepsis and sepsis-induced kidney injury. , 2009, The Journal of clinical investigation.

[21]  N. Webster,et al.  Immunomodulation in the critically ill , 2009, British Journal of Anaesthesia.

[22]  S. Akira,et al.  Protection from lethal Gram-negative bacterial sepsis by targeting Toll-like receptor 4 , 2009, Proceedings of the National Academy of Sciences.

[23]  A. Guglielmotti,et al.  Role of MCP-1 in endotoxemia and sepsis. , 2008, International immunopharmacology.

[24]  R. Bellomo,et al.  Potential interventions in sepsis-related acute kidney injury. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[25]  D. Brenner,et al.  Mechanisms of Fibrogenesis , 2008, Experimental biology and medicine.

[26]  R. Jerala.  Structural biology of the LPS recognition. , 2007, International journal of medical microbiology : IJMM.

[27]  D. Basile.  The endothelial cell in ischemic acute kidney injury: implications for acute and chronic function. , 2007, Kidney international.

[28]  Philip R Mayeux,et al.  Evidence for the role of reactive nitrogen species in polymicrobial sepsis-induced renal peritubular capillary dysfunction and tubular injury. , 2007, Journal of the American Society of Nephrology : JASN.

[29]  A. Karsan,et al.  Lipopolysaccharide signaling in endothelial cells , 2006, Laboratory Investigation.

[30]  M. Heinzelmann,et al.  Heparin Binds to Lipopolysaccharide (LPS)-Binding Protein, Facilitates the Transfer of LPS to CD14, and Enhances LPS-Induced Activation of Peripheral Blood Monocytes1 , 2005, The Journal of Immunology.

[31]  K. Brandenburg,et al.  Phospholipids Inhibit Lipopolysaccharide (LPS)-Induced Cell Activation: A Role for LPS-Binding Protein1 , 2005, The Journal of Immunology.

[32]  M. Matthay,et al.  Soluble MD-2 activity in plasma from patients with severe sepsis and septic shock. , 2004, Blood.

[33]  F. Haddy,et al.  Acute renal failure and sepsis. , 2004, The New England journal of medicine.

[34]  P. Tobias,et al.  Toll‐like receptor 4 functions intracellularly in human coronary artery endothelial cells: roles of LBP and sCD14 in mediating LPS‐responses , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[35]  A. Karsan,et al.  Lipopolysaccharide initiates a TRAF6-mediated endothelial survival signal. , 2004, Blood.

[36]  S. Morgera,et al.  TNF-alpha elimination with high cut-off haemofilters: a feasible clinical modality for septic patients? , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[37]  C. Singer,et al.  Secretory functions of smooth muscle: cytokines and growth factors. , 2002, Molecular interventions.

[38]  C. Sessler,et al.  New concepts in sepsis , 2002, Current opinion in critical care.

[39]  G. Camussi,et al.  Urinary soluble CD14 mediates human proximal tubular epithelial cell injury induced by LPS. , 2002, International journal of molecular medicine.

[40]  K. Triantafilou,et al.  Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. , 2002, Trends in immunology.

[41]  Rinaldo Bellomo,et al.  A pilot study of coupled plasma filtration with adsorption in septic shock* , 2002, Critical care medicine.

[42]  L. Truong,et al.  Peritubular capillary loss is associated with chronic tubulointerstitial injury in human kidney: altered expression of vascular endothelial growth factor. , 2000, Human pathology.

[43]  P. Godowski,et al.  Toll-Like Receptor 4, But Not Toll-Like Receptor 2, Is a Signaling Receptor for Escherichia and Salmonella Lipopolysaccharides1 , 2000, The Journal of Immunology.

[44]  R. Bellomo,et al.  Adsorption in sepsis. , 2000, Kidney international. Supplement.

[45]  G. Su,et al.  Kupffer cell activation by lipopolysaccharide in rats: Role for lipopolysaccharide binding protein and toll‐like receptor 4 , 2000, Hepatology.

[46]  D. Golenbock,et al.  LPS‐binding proteins and receptors , 1998, Journal of leukocyte biology.

[47]  R. T. Jones,et al.  Ultrastructural study on kidney cell injury following various types of shock in 26 immediate autopsy patients. , 1978, Advances in shock research.